ELAPOR1 (Gene)

Synonyms:EIG121, ELAPOR1, ENTREZ:57535, HGNC:29618, KIAA1324, MIM:611298, NM_001267048, NM_001267049, NM_001284352, NM_001284353, NM_020775, NP_001253977, NP_001271281, NP_001271282, NP_065826, XM_011541825, XM_011541826, XM_011541827, XM_017001883, XP_011540127, XP_011540128, XP_011540129, XP_016857372, endosome-lysosome associated apoptosis and autophagy regulator 1
Omim:OMIM:611298
Id:95a90571-79eb-5b80-9f40-344c07e792b1
Hgnc:HGNC:29618
Entrez:57535
Description:endosome-lysosome associated apoptosis and autophagy regulator 1
Expression of this gene is induced by estrogen and the encoded protein has been characterized as a transmembrane protein. The encoded protein has been found in to correlate with survival in certain carcinomas (PMID: 21102415) and may be important for cellular response to stress (PMID: 21072319). Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2012]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ELAPOR1's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ELAPOR1.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ELAPOR1.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ELAPOR1.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ELAPOR1.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.